ArticleHuman vaccines & immunotherapeutics2026

Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer.

Jing Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.